Literature DB >> 16904942

Imaging in gynecology.

Lil Valentin1.   

Abstract

This chapter summarizes the diagnostic performance (sensitivity, specificity, positive and negative likelihood ratios) of ultrasound, computer tomography, and magnetic resonance imaging in the diagnosis of various gynecological diseases and tumors. Positron emission tomography is not discussed. Imaging in infertility, in the diagnosis of Mullerian duct anomalies and in gynecological oncology (staging of gynecological cancers, diagnosis of recurrence of gynecological cancer, diagnosis of trophoblastic tumors) is not dealt with. Ultrasound is the first-line imaging method for discrimination between viable intrauterine pregnancy, miscarriage and tubal pregnancy in women with bleeding and/or pain in early pregnancy, for discrimination between benign and malignant adnexal masses and for making a specific diagnosis in adnexal tumors (e.g. dermoid cyst, endometrioma, hemorrhagic corpus luteum, etc.), for diagnosing intracavitary uterine pathology in women with bleeding problems, and for confirming or refuting pelvic pathology in women with pelvic pain. Magnetic resonance imaging can have a role as a secondary test in the diagnosis of adenomyosis, 'deep endometriosis' (e.g. endometriosis in the rectovaginal septum or in the uterosacral ligaments), and in the diagnosis of extremely rare types of ectopic pregnancy (e.g. in the spleen, liver or retroperitoneum).

Entities:  

Mesh:

Year:  2006        PMID: 16904942     DOI: 10.1016/j.bpobgyn.2006.06.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  8 in total

1.  Contrast-enhanced ultrasonography using Sonazoid(®) is useful for diagnosis of malignant ovarian tumors: comparison with Doppler ultrasound.

Authors:  Shoko Kumazawa; Tomokazu Umezu; Yuko Kanayama; Naohisa Kamiyama; Shiro Suzuki; Mika Mizuno; Hiroaki Kajiyama; Kiyosumi Shibata; Fumitaka Kikkawa
Journal:  J Med Ultrason (2001)       Date:  2012-07-04       Impact factor: 1.314

2.  In vivo high-resolution magnetic resonance elastography of the uterine corpus and cervix.

Authors:  Xuyuan Jiang; Patrick Asbach; Kaspar-Josche Streitberger; Anke Thomas; Bernd Hamm; Jürgen Braun; Ingolf Sack; Jing Guo
Journal:  Eur Radiol       Date:  2014-07-21       Impact factor: 5.315

Review 3.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

4.  Misdiagnosed uterine rupture of an advanced cornual pregnancy.

Authors:  Christian Linus Hastrup Sant; Poul Erik Andersen
Journal:  Case Rep Radiol       Date:  2012-04-03

Review 5.  Non-invasive tools for the diagnosis of potentially life-threatening gynaecological emergencies: a systematic review.

Authors:  Viola Polena; Cyrille Huchon; Catalina Varas Ramos; Roman Rouzier; Alexandre Dumont; Arnaud Fauconnier
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

6.  Classification of images acquired with colposcopy using artificial neural networks.

Authors:  Priscyla W Simões; Narjara B Izumi; Ramon S Casagrande; Ramon Venson; Carlos D Veronezi; Gustavo P Moretti; Edroaldo L da Rocha; Cristian Cechinel; Luciane B Ceretta; Eros Comunello; Paulo J Martins; Rogério A Casagrande; Maria L Snoeyer; Sandra A Manenti
Journal:  Cancer Inform       Date:  2014-10-31

Review 7.  Hemorrhagic corpus luteum: Clinical management update.

Authors:  Mykhailo V Medvediev; Antonio Malvasi; Sarah Gustapane; Andrea Tinelli
Journal:  Turk J Obstet Gynecol       Date:  2020-12-10

8.  Vessel morphology depicted by three-dimensional power Doppler ultrasound as second-stage test in adnexal tumors that are difficult to classify: prospective diagnostic accuracy study.

Authors:  P Sladkevicius; L Jokubkiene; D Timmerman; D Fischerova; C Van Holsbeke; D Franchi; L Savelli; E Epstein; R Fruscio; J Kaijser; A Czekierdowski; S Guerriero; M A Pascual; A C Testa; L Ameye; L Valentin
Journal:  Ultrasound Obstet Gynecol       Date:  2021-02       Impact factor: 7.299

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.